GB0012293D0 - Pharmaceutical combination - Google Patents

Pharmaceutical combination

Info

Publication number
GB0012293D0
GB0012293D0 GBGB0012293.7A GB0012293A GB0012293D0 GB 0012293 D0 GB0012293 D0 GB 0012293D0 GB 0012293 A GB0012293 A GB 0012293A GB 0012293 D0 GB0012293 D0 GB 0012293D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical combination
pharmaceutical
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0012293.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GBGB0012293.7A priority Critical patent/GB0012293D0/en
Publication of GB0012293D0 publication Critical patent/GB0012293D0/en
Priority to EP01937066A priority patent/EP1292297A1/fr
Priority to AU2001262834A priority patent/AU2001262834A1/en
Priority to JP2001585760A priority patent/JP2003534279A/ja
Priority to US10/276,112 priority patent/US20030114519A1/en
Priority to PCT/SE2001/001163 priority patent/WO2001089516A1/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0012293.7A 2000-05-23 2000-05-23 Pharmaceutical combination Ceased GB0012293D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB0012293.7A GB0012293D0 (en) 2000-05-23 2000-05-23 Pharmaceutical combination
EP01937066A EP1292297A1 (fr) 2000-05-23 2001-05-22 Combinaison pharmaceutique de bicalutamide et d'anastrozole permettant d'obtenir un effet anti-androgene et l'inhibition de l'aromatase
AU2001262834A AU2001262834A1 (en) 2000-05-23 2001-05-22 Pharmaceutical combination of bicalutamide and anastrozole for providing an anti-androgenic effect and aromatase inhibition
JP2001585760A JP2003534279A (ja) 2000-05-23 2001-05-22 抗アンドロゲン作用およびアロマターゼ阻害を与えるためのビカルタミドおよびアナストロゾールの医薬組合せ
US10/276,112 US20030114519A1 (en) 2000-05-23 2001-05-22 Pharmaceutical combination of bicalutamide and anastrozole for providing an anti-androgenic effect and aromatase inhibition
PCT/SE2001/001163 WO2001089516A1 (fr) 2000-05-23 2001-05-22 Combinaison pharmaceutique de bicalutamide et d'anastrozole permettant d'obtenir un effet anti-androgene et l'inhibition de l'aromatase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0012293.7A GB0012293D0 (en) 2000-05-23 2000-05-23 Pharmaceutical combination

Publications (1)

Publication Number Publication Date
GB0012293D0 true GB0012293D0 (en) 2000-07-12

Family

ID=9892040

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0012293.7A Ceased GB0012293D0 (en) 2000-05-23 2000-05-23 Pharmaceutical combination

Country Status (5)

Country Link
EP (1) EP1292297A1 (fr)
JP (1) JP2003534279A (fr)
AU (1) AU2001262834A1 (fr)
GB (1) GB0012293D0 (fr)
WO (1) WO2001089516A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2500062E (pt) 2007-11-13 2015-10-12 Curadis Gmbh Esteroides c-19 para utilizações terapêuticas específicas
CN102988313A (zh) * 2011-09-14 2013-03-27 北京以岭生物工程技术有限公司 一种阿那曲唑分散片及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3121152A1 (de) * 1981-05-22 1982-12-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen "verwendung der kombination eines aromatase-hemmers mit einem antiandrogen zur prophylaxe und therapie der prostatahyperplasie"
ATE28864T1 (de) * 1982-07-23 1987-08-15 Ici Plc Amide-derivate.
GB8714013D0 (en) * 1987-06-16 1987-07-22 Ici Plc (substituted-aralkyl)heterocyclic compounds
US4895715A (en) * 1988-04-14 1990-01-23 Schering Corporation Method of treating gynecomastia
JPH09508125A (ja) * 1994-01-21 1997-08-19 セプラコー，インコーポレイテッド 光学的純正ｒ−（−）−カソデックスを使用した男性ホルモン依存疾患治療のための方法と組成
GB9930839D0 (en) * 1999-12-30 2000-02-16 Pharmacia & Upjohn Spa Process for treating gynecomastia

Also Published As

Publication number Publication date
JP2003534279A (ja) 2003-11-18
EP1292297A1 (fr) 2003-03-19
AU2001262834A1 (en) 2001-12-03
WO2001089516A1 (fr) 2001-11-29

Similar Documents

Publication Publication Date Title
GB0006133D0 (en) Novel pharmaceutical
GB0020691D0 (en) Pharmaceutical combination
GB0025473D0 (en) Pharmaceutical combinations
GB0031084D0 (en) Pharmaceutical compounds
GB0012291D0 (en) Pharmaceutical combination
GB0019228D0 (en) Novel pharmaceutical
GB0021865D0 (en) Novel pharmaceutical
GB0019272D0 (en) Pharmaceutical compounds
GB0014006D0 (en) Novel pharmaceutical
GB0024318D0 (en) Pharmaceutical compounds
GB0019224D0 (en) Novel pharmaceutical
GB0019226D0 (en) Novel pharmaceutical
GB0021487D0 (en) Pharmaceutical
GB0014005D0 (en) Novel pharmaceutical
GB0023971D0 (en) Novel pharmaceutical
GB0005366D0 (en) Pharmaceutical compounds
GB0012293D0 (en) Pharmaceutical combination
GB0019223D0 (en) Novel pharmaceutical
GB0023970D0 (en) Novel pharmaceutical
GB0021785D0 (en) Novel Pharmaceutical
GB0020767D0 (en) Pharmaceutical combination
GB0016426D0 (en) Pharmaceutical combination
GB0017668D0 (en) Pharmaceutical combination
GB0017666D0 (en) Pharmaceutical combination
GB0020768D0 (en) Pharmaceutical combination

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)